Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome

NCT00013689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

NIH

Sponsor class

Conditions

Autoimmune Disease
Lymphoproliferative Disorder

Interventions

DRUG: Fansidar (pyrimethamine and sulfadoxine)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)